International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report
Pediatric Allergy and Immunology · 2026-10 · 37 (10)
DOI: 10.1111/pai.70507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 14.10.2026. Verfasst von M F Gonzalez-Matamala und 29 weiteren Autor:innen. Beteiligte Einrichtung: Centro del Alergico, Santiago de Chile, Chile. Hauptthemen laut MEDLINE: Epinephrine, Anaphylaxis, Food Hypersensitivity. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Intranasal adrenaline has been approved in multiple countries for anaphylaxis treatment, based primarily on pharmacokinetic/pharmacodynamic comparisons to adrenaline autoinjectors (AAIs).
Aim
To assess patient and caregiver perspectives regarding emerging non‐injectable adrenaline routes.
Methods
Online survey of adults and caregivers of children with food allergy prescribed AAIs, with international dissemination supported by the European Academy of Allergy and Clinical Immunology (February–April 2025).
Results
We analyzed 542 responses from caregivers and 224 from adults with food allergy. Effectiveness of adrenaline nasal spray (ANS) compared to AAI was rated “extremely important” by 78% of caregivers and 71% of adults. 48% of caregivers and 42% of adults were “extremely worried” that ANS may not work as well as AAI, and 50% and 44% (respectively) that it may not work well enough. Compared with AAI, respondents were less worried about ANS being painful or difficult to carry, and about fear/embarrassment around use, but more worried about side effects and knowing how to use it. Most anticipated being more comfortable using ANS than AAI, and over half anticipated earlier use during anaphylaxis. Only 17.2% of caregivers and 23.2% of adults preferred to be prescribed ANS only. There was interest in sublingual adrenaline due to portability and reduced needle‐related burden, but confidence depended on comparable speed/effectiveness and feasibility during reactions.
Conclusions
Non‐injectable adrenaline is attractive to caregivers and adults, and may improve willingness to carry and use adrenaline. However, demand for evidence of effectiveness, safety, and real‐world feasibility is high, highlighting important information needs for shared decision‐making. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro del Alergico, Santiago de Chile, Chile.
- Allergy Department, Hospital Clínic Barcelona, Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
- Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK.
- Department of Paediatric Allergy, Imperial College Healthcare NHS Trust, London, UK.
- Allergy MSc Alumni, National Heart and Lung Institute, Imperial College London, London, UK.
ORCID-Profile: M F Gonzalez-Matamala, R Knibb, G Roberts, P J Turner, A Kazie, N Atzert, J Bartra, A Deschildre, W Feleszko, J Gerdts, M H Gowland, T T M Le, C Ozdemir, K Papadopoulou, M Podestà, M Ruano-Zaragoza, H O Skjerven, B Stoilov, L D Valderrama, C Venter, C Woehlk, M Vazquez-Ortiz
Zitieren
APA
Gonzalez-Matamala, M. F., Patel, N., Kahn-Santoro, D., Knibb, R., Roberts, G., Turner, P. J., Kazie, A., Atzert, N., Bartra, J., Chetty, K., Deschildre, A., Dumitru, F. A., Feleszko, W., Gerdts, J., Gowland, M. H., Le, T. T. M., Pité, H., Ozdemir, C., Papadopoulou, K., …, & EAACI Taskforce on Food Allergen Ingestion Risk (2026). International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report. Pediatric Allergy and Immunology, 37(10). https://doi.org/10.1111/pai.70507
Vancouver
Gonzalez-Matamala MF, Patel N, Kahn-Santoro D, Knibb R, Roberts G, Turner PJ, et al. International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report. Pediatric Allergy and Immunology. 2026;37(10). doi:10.1111/pai.70507
BibTeX
@article{GonzalezMatamala2026,
author = {Gonzalez-Matamala, M F and Patel, N and Kahn-Santoro, D and Knibb, R and Roberts, G and Turner, P J and Kazie, A and Atzert, N and Bartra, J and Chetty, K and Deschildre, A and Dumitru, F A and Feleszko, W and Gerdts, J and Gowland, M H and Le, T T M and Pité, H and Ozdemir, C and Papadopoulou, K and Podestà, M and Raviolo, C and Ruano-Zaragoza, M and Skjerven, H O and Stoilov, B and Valderrama, L D and Venter, C and Woehlk, C and Yonamine, G H and Vazquez-Ortiz, M and EAACI Taskforce on Food Allergen Ingestion Risk, EAACI Taskforce on Food Allergen Ingestion Risk},
title = {International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report},
journal = {Pediatric Allergy and Immunology},
year = {2026},
volume = {37},
number = {10},
doi = {10.1111/pai.70507}
}
EUVIMED